BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 23640873)

  • 1. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
    Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
    J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
    Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma.
    Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
    Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
    Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
    Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma.
    Peng L; Zheng X; Xue Y; Huang C; Su X; Yu S
    Ann Med; 2023; 55(2):2286337. PubMed ID: 38061392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.
    Xiao W; Hu X; Zhang C; Qin X
    Endocr Res; 2023 Oct; 48(4):112-119. PubMed ID: 37606889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
    Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
    Tang T; Li J; Zheng L; Zhang L; Shi J
    Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.